Voglibose

Spécifications

83480-29-9Numéro CAS

(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrolNom IUPAC

C10H21NO7Formule chimique

267.28 g/molMasse molaire

voglibose; 83480-29-9; Basen; Glustat; Voglibosa; AO-128; Voglibosum; DTXSID2021442; A-71100; N-(1,3-Dihydroxy-2-propyl)valiolamine; S77P977AG8; DTXCID901442; (1S,2S,3R,4S,5S)-5-[(1,3-dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; (1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; RefChem:902044; A10BF03; 3,4-Dideoxy-4-(2-hydroxy-1-(hydroxymethyl)ethylamino)-2-C-(hydroxymethyl)-D-epi-inositol; (1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol; (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; CHEMBL476960; 3,4-Dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositol; AO 128; MFCD00865496; Basen OD; (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol; C10H21NO7; Voglibose [INN]; (1S,2S,3R,4S,5S)-5-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; CAS-83480-29-9; Basen (TN); Voglibose [USAN:INN]; Voglibosum [INN-Latin]; Voglibosa [INN-Spanish]; UNII-S77P977AG8; CCRIS 4540; NCGC00164595-01; (1S,2S,3R,4S,5S)-5-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; 112653-29-9; VOG; Voglibose Impurity 34; VOGLIBOSE [JAN]; VOGLIBOSE [MI]; VOGLIBOSE [USAN]; VOGLIBOSE [MART.]; SCHEMBL5882; VOGLIBOSE [WHO-DD]; A 71100; MLS003882582; Voglibose - Bio-X trade mark; orb1221743; orb1300524; Voglibose (JP18/USAN/INN); CHEBI:32300; DTXSID501031239; GLXC-06681; HMS3414A17; HMS3678A17; Voglibose, >=97.0% (TLC); HY-B0025; MSK10642; Tox21_112220; BDBM50263044; AKOS015950839; Tox21_112220_1; CCG-267119; DB04878; MV06910; NCGC00164595-02; 3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]AMINO]-2-C-(HYDROXYMETHYL)-D-EPINOSITOL; BV164530; SMR002530327; SY108971; NS00069197; T6723; V5725; D01665; AB01566929_01; F818267; SR-01000883931; Q7939403; SR-01000883931-1; BRD-K66850609-001-01-7; BRD-K66850609-001-05-8; BRD-K66850609-001-07-4; 2,3-Dideoxy-2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-4-C-(hydroxymethyl)-epi-inositol; 3,4-Dideoxy-[2-hydroxy-1-(hydroxyethyl)ethyl] amino-1-C-(hydroxymethyl)-1,2,3,4-cyclohexaneterol; 3,4-Dideoxy-4-[[2-hy droxy-1-(hydr oxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol; D-epi-Inositol, 3,4-dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-Synonymes